PATENT CLAIM ANALYSIS

Application Number: 16110713
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "020900"]

Abstract:
A series of peptides and a peptide-siRNA complex are disclosed, wherein the peptide based complex effectively enhances delivery of siRNA molecules into the cells and release of siRNA in the cell, and improves siRNA mediated gene silencing efficiency of cellular targets. Pharmaceutical compositions that include the complex, as well as a use of the complex in the gene therapy field, are also disclosed.

Claim (Index 9):
The complex according to  claim 6 , wherein the siRNA is complexed with the peptide at a molar ratio of about 40:1.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.60465
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15106108', '15407802', '14983194', '14359873', '12390913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8039537683622024
- 35 USC 102 Novelty (BERT): 0.5762170293672085
- Combined Prediction Score: 0.7811800944627031
- Mean Citation Score: 368.751476
- Max Citation Score: 528.6619999999998
- Similarity Product: 362.0563645513057

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test